Fredun Pharmaceuticals Ltd.

•

fredungroup.comBSE: -NSE: FREDUN

Market Cap₹ 2,338 Cr.

Current Price

High / Low₹ 1,590 / 1,320

Stock P/E53.3

Book Value₹ 177

Price to Book3.46

Dividend Yield0.02 %

ROCE21.3 %

ROE16.1 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Latest quarter profit grew 94.1% YoY, showing strong momentum
Institutional investors have been accumulating - FII+DII up 2.4pp

CONS

Promoter holding has decreased over last 2 years: -4.6pp
Working capital days have increased from 80 to 116 days
Total debt has risen sharply - up 33.1% year on year

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	FREDUN	1413.55	53.35	2337.74	0.02	131.32	94.09	2282.48	90.44	21.34	14.34

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	0	1,674	1,199	1,453	1,609	2,131	2,282
	0	1,601	1,108	1,326	1,469	2,018	2,077
Operating Profit	0	73	90	127	140	112	206
OPM %	—	4.34%	7.54%	8.75%	8.70%	5.28%	9.00%
	0	0	0	0	0	0	0
Interest	0	81	65	77	106	145	86
Depreciation	0	18	14	19	18	32	36
Profit before Tax	0	73	90	127	140	112	206
Tax %	—	17.36%	25.17%	25.77%	25.17%	4.16%	36.10%
Net Profit	0	60	68	94	105	108	131
	0.00	12.71	14.33	19.98	19.53	19.70	23.82

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2025	Mar 2026	TTM
	454	635	7,475
	401	545	6,890
Operating Profit	52	91	585
OPM %	11.56%	14.31%	7.83%
	2	4	0
Interest	22	39	414
Depreciation	5	8	104
Profit before Tax	27	47	585
Tax %	28.20%	30.59%	25.10%
Net Profit	20	33	438
EPS	41.80	59.61	—
Dividend Payout %	1.67%	1.17%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: —
Last Year:: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2025	Mar 2026
Equity Capital	5	5
	137	259
	160	203
Trade Payables	145	88
	41	88
Total Liabilities	487	642
	53	118
	2	2
	240	270
	177	93
Cash & Bank	5	65
	11	94
Total Assets	487	642

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2025	Mar 2026
	-17	12
Cash from Investing	-6	-74
Cash from Financing	27	121
	4	60

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	49.17	48.93	48.93	48.93	48.93	48.93	43.06	44.17	44.57
	0.00	0.00	0.00	0.00	0.00	0.01	0.46	1.06	1.06
	1.60	1.59	1.59	1.59	1.59	1.61	3.48	2.83	2.94
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	49.24	49.48	49.48	49.48	49.48	49.45	53.00	51.94	51.43

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for FREDUN

Loading news…

🤖

AI Stock Analyst

Fredun Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

FREDUN

1413.55

53.35

2337.74

0.02

131.32

94.09

2282.48

90.44

21.34

14.34

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

1,674

1,199

1,453

1,609

2,131

2,282

1,601

1,108

1,326

1,469

2,018

2,077

Operating Profit

127

140

112

206

OPM %

—

4.34%

7.54%

8.75%

8.70%

5.28%

9.00%

Interest

106

145

Depreciation

Profit before Tax

127

140

112

206

Tax %

—

17.36%

25.17%

25.77%

25.17%

4.16%

36.10%

Net Profit

105

108

131

0.00

12.71

14.33

19.98

19.53

19.70

23.82

Mar 2025

Mar 2026

TTM

454

635

7,475

401

545

6,890

Operating Profit

585

OPM %

11.56%

14.31%

7.83%

Interest

414

Depreciation

104

Profit before Tax

585

Tax %

28.20%

30.59%

25.10%

Net Profit

438

EPS

41.80

59.61

—

Dividend Payout %

1.67%

1.17%

—

Mar 2025

Mar 2026

Equity Capital

137

259

160

203

Trade Payables

145

Total Liabilities

487

642

118

240

270

177

Cash & Bank

Total Assets

487

642

Mar 2025

Mar 2026

-17

Cash from Investing

-6

-74

Cash from Financing

121

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

49.17

48.93

43.06

44.17

44.57

0.00

0.01

0.46

1.06

1.60

1.59

1.61

3.48

2.83

2.94

Government

0.00

49.24

49.48

49.45

53.00

51.94

51.43

Fredun Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Fredun Pharmaceuticals Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI